Should you buy, sell or hold Infosys, TCS, HCL Tech, BEL, PB Fintech, PNB Housing and other stocks in focus today?

Which stocks to buy, hold or sell today? As Dalal Street enters the April 3 session, here's a look at what brokerages make of some of the key stocks in focus. Stocks such as BEL, ONGC, PB Fintech, PNB Housing Finance, Infosys, TCS, Wipro, Tech Mahindra, and other IT shares are on their radar.

Here is a list of brokerage calls on some of the stocks in focus today, including BEL, ONGC, PB Fintech, Infosys, TCS. | Image Source: Pixabay

Which stocks to buy, hold or sell today? As Dalal Street enters the April 3 session, here's a look at what brokerages make of some of the key stocks in focus.

Stocks such as Bharat Electronics Limited (BEL), ONGC, PB Fintech, PNB Housing Finance, Infosys, TCS, Wipro, Tech Mahindra and other IT shares are on their radar today.

Do you have any of these stocks in your portfolio?

TRENDING NOW

Check out the full list of what brokerages recommend, including IT shares, BEL, PB Fintech, PNB Housing Finance, Zydus Lifesciences and among other stocks:

Brokerages on IT stocks

Ahead of fourth-quarter results for the financial year 2022-23 (Q4FY23), global brokerages are upbeat on IT heavyweights such as HCL Technologies, Infosys, TCS, Wipro, and Tech Mahindra, recommending to ‘buy’ these shares.

HCL Technologies shares

Brokerage	Rating	Price Target
CLSA	Outperform	Rs 1,200
Nomura	Neutral	Rs 1,150
HSBC	Buy	Rs 1,230
Macquarie	Outperform	Rs 1,580

Infosys shares

Brokerage	Rating	Price Target
CLSA	Buy	Rs 1,800
Nomura	Buy	Rs 1,660

TCS shares

Brokerage	Rating	Price Target
CLSA	Outperform	Rs 3,550
Nomura	Reduce	Rs 2,850

Tech Mahindra shares

Brokerage	Rating	Price Target
CLSA	Outperform	Rs 1,200
Nomura	Buy	Rs 1,250

Wipro shares

Brokerage	Rating	Price Target
CLSA	Outperform	Rs 450
Nomura	Neutral	Rs 380

PNB Housing Finance shares

Morgan Stanley maintained an ‘overweight’ stance on PNB Housing Finance with a target price of Rs 700 per share. The brokerage estimates that the base case profit after tax of the company would rise by 8-9 per cent for FY24-25, amid expected lower funding costs.

Zydus Lifesciences shares

Morgan Stanley also maintained an ‘overweight’ stance on Zydus Lifesciences with a target price of Rs 513 per share as the brokerage expects good earnings momentum for the company. It said core business and niche US opportunities like REcvilimind and Trokendi will aid growth.

PB Fintech shares

CLSA downgrade PB Fintech to ‘accumulate’ from ‘buy’ with an increased target price of Rs 710 per share from Rs 660 apiece earlier.

Bharat Electronics Limited (BEL) shares

CLSA has a ‘buy’ rating on Bharat Electronics with a revised target price of Rs 115 apiece. Similarly, Morgan Stanley retained an ‘overweight’ rating on BEL with a target of Rs 119

Brokerage	Rating	Price Target
CLSA	Buy	Rs 115
Morgan Stanley	Overweight	Rs 119

According to CLSA, FY23 orders are in-line but execution below. It added while its specialty defense electronics firm has an impressive $7 billion 3-year backlog, it's set for large orders in FY24-26 from an over $15 billion nomination pipeline.

Click here to catch latest updates on monthly auto sales. Are your favourite cars or motorcycles among the top-selling models?

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.

TAGS:

Bharat Electronics Limited (BEL)ONGC pb fintech PNB Housing Finance Infosys TCS Wipro Tech Mahindra IT shares